Following these sales, Borgeson directly holds 6,199,863 shares of Recursion Pharmaceuticals. The sale was executed under a Rule 10b5-1 trading plan, which Borgeson adopted on August 31, 2025.The ...
Christopher Gibson, a director at RECURSION PHARMACEUTICALS, INC. (NASDAQ:RXRX), sold 40,000 shares of Class A Common Stock on May 7, 2026, for a total value of $134,800. The shares were sold at a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results